Traws Pharma (TRAW) Proxy Filing summary

Executive summary

• The annual meeting will be held virtually on October 31, 2024, with voting on key proposals including director elections, incentive plan amendments, executive compensation, and auditor ratification.

• A one-for-twenty-five reverse stock split was effected on September 20, 2024, and all share figures are retroactively adjusted.

• The record date for voting is September 27, 2024, with 3,025,431 shares of common stock outstanding and entitled to vote.

Voting matters and shareholder proposals

• Proposals include electing seven directors, amending and restating the 2021 Incentive Compensation Plan, an advisory vote on executive compensation, and ratifying KPMG LLP as the independent auditor.

• The board recommends voting FOR all proposals.

• Shareholders can vote by mail, phone, internet, or during the virtual meeting.

Board of directors and corporate governance

• The board consists of seven members, with six deemed independent under NASDAQ rules.

• Board committees include audit, compensation, and nominating/governance, each with defined charters and independent members.

• The board separates the roles of CEO and chairman for governance effectiveness.

• Board diversity is disclosed, with two female and five male directors as of October 2024.